New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricle

Clinical Genetics

Volumn 80, Issue 2, 2011, Pages 184-190

  De Luca, A ^a   Sarkozy, A ^a,e   Ferese, R ^a,b   Consoli, F ^a,b   Lepri, F ^a   Dentici, Ml ^a   Vergara, P ^a   De Zorzi, A ^c   Versacci, P ^d   Digilio, Mc ^c   Marino, B ^d   Dallapiccola, B ^c  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Congenital heart defects; Conotruncal defects; Double outlet right ventricle; GATA4; GDF1; ISLET1; NKX2.5; Tetralogy of Fallot; ZFPM2 FOG2

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 1; HYBRID PROTEIN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG; ZFPM2 FOG2 FUSION PROTEIN;

ARTICLE; CONGENITAL HEART DISEASE; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FALLOT TETRALOGY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HEART RIGHT VENTRICLE DOUBLE OUTLET; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PULMONARY VALVE ATRESIA;

BASE SEQUENCE; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; DOUBLE OUTLET RIGHT VENTRICLE; GATA4 TRANSCRIPTION FACTOR; GROWTH DIFFERENTIATION FACTOR 1; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; TETRALOGY OF FALLOT; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 79960209628     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01523.x     Document Type: Article

References (46)

1. Neches WH, Park SC, Ettedgui JA. Tetralogy of Fallot and tetralogy of Fallot with pulmonary atresia. In: Garson A, Bricker JT, Fisher DJ et al., eds. The science and practice of pediatric cardiology, Vol. 2. Baltimore: Williams & Williams, 1998: 1383-1413.
2. Marino B, Digilio MC. Congenital heart disease and genetic syndromes: specific correlation between cardiac phenotype and genotype. Cardiovasc Pathol 2000: 9 (6): 303-315.
3. Digilio MC, Casey B, Toscano A et al. Complete transposition of the great arteries: patterns of congenital heart disease in familial precurrence. Circulation 2001: 104 (23): 2809-2814.
4. De Luca A, Sarkozy A, Consoli F et al. Familial transposition of great arteries caused by multiple mutations in laterality genes. Heart 2010: 96 (9): 673-677.
5. Goldmuntz E, Bamford R, Karkera JD et al. CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle. Am J Hum Genet 2002: 70 (3): 776-780.
6. Calcagni G, Digilio MC, Sarkozy A et al. Familial recurrence of congenital heart disease: an overview and review of the literature. Eur J Pediatr 2007: 166 (2): 111-116.
7. Oyen N, Poulsen G, Boyd HA et al. Recurrence of congenital heart defects in families. Circulation 2009: 120 (4): 295-301.
8. Ferencz C, Loffredo CA, Correa-Villasenor A et al. Malformations of the cardiac outflow tract. In: Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington Infant Study 1981-1989. Armonk, New York: Fuytura Publishing Co, 1997: 59-102.
9. Beauchesne LM, Warnes CA, Connolly HM et al. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol 2005: 45 (4): 595-598.
10. Greenway SC, Pereira AC, Lin JC et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 2009: 41 (8): 931-935.
11. Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of Fallot. Circulation 2001: 104 (21): 2565-2568.
12. McElhinney DB, Geiger E, Blinder J et al. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 2003: 42 (9): 1650-1655.
13. Tomita-Mitchell A, Maslen CL, Morris CD et al. GATA4 sequence variants in patients with congenital heart disease. J Med Genet 2007: 44 (12): 779-783.
14. Nemer G, Fadlalah F, Usta J et al. A novel mutation in the GATA4 gene in patients with tetralogy of Fallot. Hum Mutat 2006: 27 (3): 293-294.
15. Zhang WM, Li XF, Ma ZY et al. GATA4 and NKX2.5 gene analysis in Chinese Uygur patients with congenital heart disease. Chin Med J 2009: 122 (4): 416-419.
16. Pizzuti A, Sarkozy A, Newton AL et al. Mutations of ZFPM2/ FOG2 gene in sporadic cases of tetralogy of Fallot. Hum Mutat 2003: 22 (5): 372-377.
17. Roessler E, Ouspenskaia MV, Karkera JD et al. Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly. Am J Hum Genet 2008: 83 (1): 18-29.
18. Roessler E, Pei W, Ouspenskaia MV et al. Cumulative ligand activity of NODAL mutations and modifiers are linked to human heart defects and holoprosencephaly. Mol Genet Metabol 2009: 98 (1-2): 225-234.
19. Karkera JD, Lee JS, Roessler E et al. Loss-of-function mutations in growth differentiation factor-1 (GDF1) are associated with congenital heart defects in humans. Am J Hum Genet 2007: 81 (5): 987-994.
20. Prescott K, Woodfine K, Stubbs P et al. A novel 5q11.2 deletion detected by microarray comparative genomic hybridisation in a child referred as a case of suspected 22q11 deletion syndrome. Hum Genet 2005: 116 (1-2): 83-90.
21. Amati F, Mari A, Digilio MC et al. 22q11 deletions in isolated and syndromic patients with tetralogy of Fallot. Hum Genet 1995: 95 (5): 479-482.
22. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 2001: 11 (5): 863-874.
23. Sunyaev S, Ramensky V, Bork P. Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet 2000: 16 (5): 198-200.
24. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998: 17 (8): 857-872.
25. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927: 22: 209-212.
26. Bottillo I, De Luca A, Schirinzi A et al. Functional analysis of splicing mutations in exon 7 of NF1 gene. BMC Med Genet 2007: 8: 4.
27. Akcaboy MI, Cengiz FB, Inceoglu B et al. The effect of p.Arg25Cys alteration in NKX2-5 on conotruncal heart anomalies: mutation or polymorphism? Pediatric Cardiol 2008: 29 (1): 126-129.
28. Gioli-Pereira L, Pereira AC, Mesquita SM et al. NKX2.5 mutations in patients with non-syndromic congenital heart disease. Int J Cardiol 2010: 138 (3): 261-265.
29. Benson DW, Silberbach GM, Kavanaugh-McHugh A et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 1999: 104 (11): 1567-1573.
30. Dentice M, Cordeddu V, Rosica A et al. Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. J Clin Endocrinol Metab 2006: 91 (4): 1428-1433.
31. Esposito G, Grutter G, Drago F et al. Molecular analysis of PRKAG2, LAMP2, and NKX2-5 genes in a cohort of 125 patients with accessory atrioventricular connection. Am J Med Genet A 2009: 149A (7): 1574-1577.
32. Cai CL, Liang X, Shi Y et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003: 5 (6): 877-889.
33. Stevens KN, Hakonarson H, Kim CE et al. Common variation in ISL1 confers genetic susceptibility for human congenital heart disease. PLoS One 2010: 5 (5): e10855.
34. Henrick K, Thornton JM. PQS: a protein quaternary structure file server. Trends Biochem Sci 1998: 23 (9): 358-361.
35. Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983: 22 (12): 2577-2637.
36. Svensson EC, Huggins GS, Lin H et al. A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2. Nat Genet 2000: 25 (3): 353-356.
37. Tevosian SG, Deconinck AE, Tanaka M et al. FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell 2000: 101 (7): 729-739.
38. Bamford RN, Roessler E, Burdine RD et al. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet 2000: 26 (3): 365-369.
39. Selamet Tierney ES, Marans Z, Rutkin MB et al. Variants of the CFC1 gene in patients with laterality defects associated with congenital cardiac disease. Cardiol Young 2007: 17 (3): 268-274.
40. Obler D, Juraszek AL, Smoot LB et al. Double outlet right ventricle: aetiologies and associations. J Med Genet 2008: 45 (8): 481-497.
41. Gelb BD, Towbin JA, McCabe ER et al. San Luis Valley recombinant chromosome 8 and tetralogy of Fallot: a review of chromosome 8 anomalies and congenital heart disease. Am J Med Genet 1991: 40 (4): 471-476.
42. Ackerman KG, Herron BJ, Vargas SO et al. Fog2 is required for normal diaphragm and lung development in mice and humans. PLoS Genet 2005: 1 (1): 58-65.
43. Bleyl SB, Moshrefi A, Shaw GM et al. Candidate genes for congenital diaphragmatic hernia from animal models: sequencing of FOG2 and PDGFRalpha reveals rare variants in diaphragmatic hernia patients. Eur J Hum Genet 2007: 15 (9): 950-958.
44. Graziano JN. Cardiac anomalies in patients with congenital diaphragmatic hernia and their prognosis: a report from the Congenital Diaphragmatic Hernia Study Group. J Pediatr Surg 2005: 40 (6): 1045-1049; discussion 1049-1050.
45. Kasahara H, Lee B, Schott JJ et al. Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J Clin Invest 2000: 106 (2): 299-308.
46. Svensson EC, Huggins GS, Dardik FB et al. A functionally conserved N-terminal domain of the friend of GATA-2 (FOG-2) protein represses GATA4-dependent transcription. J Biol Chem 2000: 275 (27): 20762-20769.